Navigation Links
Cost of Psoriasis Drugs Rising Faster Than Others
Date:1/18/2010

Increases outpace consumer products as well as other meds, study finds,,

MONDAY, Jan. 18 (HealthDay News) -- The cost of treating psoriasis is rising faster than inflation, says a U.S. study, which also found that newer, biologically-derived treatments cost more than traditional systemic therapies.

The researchers created a cost model to analyze the total cost of systemic therapy for psoriasis, a chronic autoimmune skin disease that affects 4.5 million to 7.5 million Americans and costs the nation's health-care industry more than $3 billion a year.

The cost for each type of systemic therapy (such as oral medications) was calculated by using the average wholesale price of each drug plus the cost of office visits, laboratory tests and monitoring.

"Current total and annual costs for systemic psoriasis therapies ranged from $1,197 (methotraxate [a traditional systemic therapy]) to $27,577 (alefacept [a biologic], two 12-week courses)," wrote Dr. Vivianne Beyer of St. Vincent Hospital in Indianapolis and Dr. Stephen E. Wolverton of the Indiana University School of Medicine.

Costs for phototherapy (exposure to ultraviolet light) ranged from $3,083 to $7,288, and costs for biologics ranged from $18,384 to $27,577.

"Trends in the average wholesale price of brand-name psoriasis therapies from 2000 through 2008 demonstrate an average increase of 66 percent," they wrote. "Thus, costs of several brand-name psoriasis drugs greatly outpaced the rate of inflation for all items and all prescription drugs."

During this time, the urban Consumer Price Index for all items increased 25.8 percent and 30.1 percent for all prescription drugs.

The study is in the January issue of the Archives of Dermatology.

"Although the tendency of psoriasis drug costs to outpace the Consumer Price Index-Urban rate is shared by both traditional and biologic therapies, traditional therapies remain much more affordable than biologic therapies," the researchers wrote. "When considering the expense of biologic therapies, even relatively small increases in price become significant, such as the 14-percent increase during an eight-year period seen with infliximib."

More information

The American Academy of Family Physicians has more about psoriasis.



-- Robert Preidt



SOURCE: JAMA/Archives journals, news release, Jan. 18, 2010


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Newer Drug More Effective in Psoriasis Treatment
2. Placebo Effect Helps Some Psoriasis Patients
3. Millions Mark World Psoriasis Day on Oct. 29
4. Largest Survey of Its Kind Finds the Psychological and Social Effects of Psoriasis Greater for Women
5. First-Ever NJ Psoriasis Walk Coming to Paramus on Sept. 12
6. Tim Gunn Hosts Addressing Psoriasis(TM) Fashion Show to Raise Awareness of Psoriasis
7. Gene variation is major genetic determinant of psoriasis
8. Psoriasis Video Contest Launched to Encourage Psoriasis Patients to Connect and Collaborate
9. Largest Survey of Its Kind Finds That People With Psoriasis Are at Risk for Other Medical Conditions
10. Winners of the Addressing Psoriasis(TM) Contest Selected to Walk the Runway in New York City Fashion Show Hosted by Tim Gunn
11. Psoriasis Cure Now Welcomes Institute of Medicine Report Urging Comparative Effectiveness Research on Psoriasis, But Worries About Risk of Rationing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... , ... October 13, 2017 , ... Yisrayl Hawkins, Pastor ... that explains one of the most popular and least understood books in the Holy ... and puzzling descriptions that have baffled scholars for centuries. Many have tossed it off ...
(Date:10/13/2017)... ... ... “America On The Brink”: the Christian history of the United States and the loss ... author, William Nowers. Captain Nowers and his wife, Millie, have six children, ten ... the Navy. Following his career as a naval aviator and carrier pilot, he ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... meet the demand of today’s consumer and regulatory authorities worldwide. From Children’s to ... and tested to meet the highest standard. , These products are also: ...
(Date:10/12/2017)... ... 12, 2017 , ... Information about the technology: , Otomagnetics ... enable prevention of a major side effect of chemotherapy in children. Cisplatin and ... For cisplatin, hearing loss is FDA listed on-label as a dose limiting toxicity. ...
(Date:10/12/2017)... , ... October 12, 2017 , ... On Saturday, October ... treadmill relay – Miles by Moonlight to raise money for the American Heart Association ... more. , Teams will work together to keep their treadmills moving for 5 ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... 2, 2017 Diplomat Pharmacy, Inc. (NYSE: ... and Consulting, LLC , and named its founder as ... in Tennessee , will operate under ... EnvoyHealth,s service offerings for health care partners to include ... "In an interoperable world, technology delivers ...
(Date:9/28/2017)... 28, 2017 Hill-Rom Holdings, Inc. (NYSE: HRC), ... call and webcast on Friday, November 3, 2017, beginning ... ending at approximately 8:30 a.m. (CDT) / 9:30 a.m. ... 2017 financial performance and guidance for 2018, Hill-Rom executives ... enhance operational performance, and long-range financial outlook through 2020. ...
(Date:9/25/2017)... , Sept. 25, 2017  EpiVax, Inc., ... vaccine design, and immune-engineering today announced the launch ... the development of personalized therapeutic cancer vaccines. EpiVax ... provided exclusive access to enabling technologies to the ... MBA will lead EpiVax Oncology as Chief Executive ...
Breaking Medicine Technology: